rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    XENE
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Xenon to Present at Upcoming Investor Conferences
      Nov 3Yahoo FinanceXENE
      Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

      VANCOUVER, BC and BOSTON, MA, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need, today announced equity inducement grants to eight new non-officer employees consisting of an aggregate of 17,850 share options and 10,500 restricted share units (RSUs). All of the foregoing share options and RSUs were a

      Oct 2Yahoo FinanceXENE
      Xenon Pharmaceuticals: Azetukalner Still Has Potential As An Epilepsy Candidate (XENE)
      Sep 22Seeking AlphaXENE
      Why This Biotech Just Erased Its One-Day 50% Pop

      Xenon Pharmaceuticals voluntarily halted enrollment in a handful of studies Friday due to several unexpected side effects.

      Sep 18Investor's Business DailyXENE
      Xenon Stock Craters 30% on Drug Trial Setback. Its Failure Could Be This Biotech’s Gain.
      Sep 18Barron'sXENE
      Xenon Pharma stock tumbles on psychiatry trial pause
      Sep 17Investing.comXENE
      Xenon to Present at Wells Fargo Healthcare Conference

      VANCOUVER, BC and BOSTON, MA, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development and commercialization of life-changing therapeutics for patients in need, today announced that the company will present at an upcoming investor conference: Wells Fargo Healthcare Conference, Boston, MAFireside Chat: Wednesday, September 9, 11:00–11:30 am ET Details about the presentation, inc

      Sep 3Yahoo FinanceXENE
      Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

      VANCOUVER, BC and BOSTON, MA, Aug. 28, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need, today announced equity inducement grants to five new non-officer employees consisting of an aggregate of 13,450 share options and 7,850 restricted share units (RSUs). All of the foregoing share options and RSUs were app

      Aug 28Yahoo FinanceXENE

      This is the newest page. Registered accounts read further back.